Home > Library
Search results : china
2025-07-01Geopolitical alignment often reshapes and reinforces asset market fragmentation in the broader context of financial deglobalization.
2025-01-01The new homeland industrial policy stance tends to tilt toward substantially improving the worldwide resilience of global supply chains.
2024-07-07Central bank digital currencies (CBDC) can affect how the central bank makes macro-financial system and monetary policy decisions in support of the dual mandate of both price stability and maximum employment.
2024-01-01Western governments use the new world order of trade to achieve non-economic goals such as national security, environmental protection, labor harmonization, and technological advancement etc.
2020-02-02This analytic report shines fresh light on the current global economic outlook as of February 2020.
2019-08-07This analytic report shines fresh light on the current global economic outlook as of August 2019.
2019-12-10 09:30:00 Tuesday ET

Federal Reserve institutes the third interest rate cut with a rare pause signal. The Federal Open Market Committee (FOMC) reduces the benchmark interest rat
2021-05-20 10:30:00 Thursday ET

Artificial intelligence, 5G, and virtual reality can help transform global trade, finance, and technology. Core trade technological advances and disruptive
2019-09-19 15:30:00 Thursday ET

U.S. yield curve inversion can be a sign but not a root cause of the next economic recession. Treasury yield curve inversion helps predict each of the U.S.
2025-06-20 08:27:00 Friday ET

President Trump poses new threats to Fed Chair monetary policy independence again. We describe, discuss, and delve into the mainstream reasons, conc
2018-01-10 08:40:00 Wednesday ET

President Trump considers imposing retaliatory economic sanctions on Chinese products and services in direct response to China's theft and infringement
2019-01-10 17:31:00 Thursday ET

The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be